An international team, led by researchers from Australia, have developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future. The researchers say the new insulin could be eaten by taking a tablet or even embedded within a piece of chocolate.
The new nano carrier, tested in mice, rats and baboon animal models, could help people with diabetes avoid side-effects linked to insulin injections such as hypoglycemia (a low blood sugar event, when too much insulin has been injected).
These animal studies have shown that the greatest strength of the nano-scale material is that it can react to the body’s blood sugar levels. The coating dissolves and releases the insulin when there is a high concentration of blood sugar and importantly does not release the insulin in low blood sugar environments.
The new oral insulin uses a type of nano-scale material that is 1/10,000th the width of a human hair. The material acts similarly to acid resistant coating on tablets, which protects it from being destroyed by stomach acid. But this new coating instead surrounds individual insulin molecules and becomes a “nano carrier”—acting like a courier to ferry insulin molecules in the body to the places it needs to act.
The findings are published in Nature Nanotechnology.
It is estimated 422 million people worldwide have diabetes, and approximately 75 million of these inject themselves with insulin daily. Around 1.5 million deaths are directly attributed to diabetes each year. In 2021, it was estimated more than 1.3 million Australians were living with diabetes.
Lead author Dr. Nicholas Hunt from the University of Sydney’s School of Medical Sciences in the Faculty of Medicine and Health, says the development of a safe and effective oral insulin has been a challenge since insulin was discovered over a century ago.
“A huge challenge that was facing oral insulin development is the low percentage of insulin that reaches the blood stream when given orally or with injections of insulin,” says Dr. Hunt, who is also a member of the University of Sydney Nano Institute and Charles Perkins Center.
“To address this, we developed a nano carrier that drastically increases the absorbance of our nano insulin in the gut when tested in human intestinal tissue.”
Preclinical testing in animal models found that, following ingestion, the nano insulin was able to control blood glucose levels without hypoglycemia or weight gain. There was also no toxicity.
“Our oral insulin has the added benefit of greatly reducing the risk of hypoglycemic episodes. For the first time we have developed an oral insulin that overcomes this major hurdle,” said Dr. Hunt.
Human trials are expected to start in 2025 led by the spin out company Endo Axiom Pty Ltd.
Endo Axiom Pty Ltd was founded by Professor Victoria Cogger, Professor David Le Couteur AO and Dr. Nicholas Hunt, after 20 years of research.
Dr. Hunt and his team were driven to develop oral insulin technology given it could help lighten the economic, health and well-being burden related to diabetes management for patients.
“We wanted to devote our time to develop successful oral insulin technology because we believe it will help people with diabetes have more control over their condition.”
Senior author Professor Victoria Cogger, director of The ANZAC Research Institute, said the development of oral insulin is the culmination of many years of scientific endeavor and collaboration.
“It’s wonderful to see our work published, supported by Endo Axiom and reaching clinical trials?—to be able to lead a change in the way we treat a disease that impacts so many people,” she said.
Professor Cogger said when her work first began on creating an oral insulin it was a purely scientific question, but then a family member became impacted by type 1 diabetes.
“Life is strange and along the way my family was impacted by a type 1 diabetes diagnosis, and I really started to understand the reality of what life is like on injectable insulin therapy.
“Having that lived experience has driven the project in many ways and created an impetus to improve life for all people living with diabetes. My hope is we can reduce the multi-faceted burden of diabetes through easily accessible oral insulin.”
More information: Nicholas J. Hunt et al, Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia, Nature Nanotechnology (2024). DOI: 10.1038/s41565-023-01565-2
Journal information: Nature Nanotechnology
Provided by University of Sydney
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
The Silent Battle Within: How Your Organs Choose Between Mom and Dad’s Genes
Research reveals that selective expression of maternal or paternal X chromosomes varies by organ, driven by cellular competition. A new study published today (July 26) in Nature Genetics by the Lymphoid Development Group at the MRC [...]
Study identifies genes increasing risk of severe COVID-19
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in [...]
Small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa
Sleep and wake: They're totally distinct states of being that define the boundaries of our daily lives. For years, scientists have measured the difference between these instinctual brain processes by observing brain waves, with [...]
Redefining Consciousness: Small Regions of the Brain Can Take Micro-Naps While the Rest of the Brain Is Awake
The study broadly reveals how fast brain waves, previously overlooked, establish fundamental patterns of sleep and wakefulness. Scientists have developed a new method to analyze sleep and wake states by detecting ultra-fast neuronal activity [...]
AI Reveals Health Secrets Through Facial Temperature Mapping
Researchers have found that different facial temperatures correlate with chronic illnesses like diabetes and high blood pressure, and these can be detected using AI with thermal cameras. They highlight the potential of this technology [...]
Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice
In a recent study published in the journal Nature, a team of researchers used murine models and various pharmacological and genetic approaches to examine whether pro-inflammatory signaling involving interleukin (IL)-11, which activates signaling molecules such [...]
Promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus. The study, [...]
New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do neurons respond to the effects of magic mushrooms? What [...]
Decoding the Decline: Scientific Insights Into Long COVID’s Retreat
Research indicates a significant reduction in long COVID risk, largely due to vaccination and the virus’s evolution. The study analyzes data from over 441,000 veterans, showing lower rates of long COVID among vaccinated individuals compared [...]
Silicon Transformed: A Breakthrough in Laser Nanofabrication
A new method enables precise nanofabrication inside silicon using spatial light modulation and laser pulses, creating advanced nanostructures for potential use in electronics and photonics. Silicon, the cornerstone of modern electronics, photovoltaics, and photonics, [...]
Caught in the actinium: New research could help design better cancer treatments
The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don't have a good grasp on the metal's chemistry. That's because actinium [...]
Innovative Light-Controlled Drugs Could Revolutionize Neuropathic Pain Treatment
A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be harnessed to target drugs to specific [...]
Green Gold: Turning E-Waste Into a Treasure Trove of Rare Earth Metals
Scientists are developing a process inspired by nature that efficiently recovers europium from old fluorescent lamps. The approach could lead to the long-awaited recycling of rare earth metals. A small molecule that naturally serves [...]
Cambridge Study: AI Chatbots Have an “Empathy Gap,” and It Could Be Dangerous
A new study suggests a framework for “Child Safe AI” in response to recent incidents showing that many children perceive chatbots as quasi-human and reliable. A study has indicated that AI chatbots often exhibit [...]
Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy
Up to 3% of people with diabetes have an allergic reaction to insulin. A team at Forschungszentrum Jülich has now studied a method that could be used to deliver the active substance into the [...]
Nanorobot kills cancer cells in mice with hidden weapon
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice. The robot's weapon is hidden in a nanostructure and is exposed only in the tumor microenvironment, sparing healthy cells. [...]